Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?
作者信息
Schluger Neil W
机构信息
Department of Medicine New York Medical College Valhalla, New York.
出版信息
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1077-1078. doi: 10.1164/rccm.202006-2488ED.
Abstract
摘要
相似文献
1
Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?密切接触者中耐多药结核病的预防。回归未来？
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1077-1078. doi: 10.1164/rccm.202006-2488ED.
2
Epidemiology, control and treatment of multidrug-resistant tuberculosis.耐多药结核病的流行病学、控制与治疗
Drugs. 1996;52 Suppl 2:103-7; discussion 107-8. doi: 10.2165/00003495-199600522-00021.
3
Multidrug-resistant tuberculosis--can the tide be turned?耐多药结核病——局势能扭转吗？
Lancet Infect Dis. 2001 Oct;1(3):199-202. doi: 10.1016/s1473-3099(01)00096-2.
4
Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom.英国耐多药结核病患儿接触者的管理
Pediatr Infect Dis J. 2013 Aug;32(8):926-7. doi: 10.1097/INF.0b013e31829157e9.
5
Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area.欧盟和欧洲经济区耐多药结核病患者接触者的管理
Int J Tuberc Lung Dis. 2012;16(3):426. doi: 10.5588/ijtld.11.0605.
6
Multidrug-resistant tuberculosis: prevention is better than cure.耐多药结核病：预防胜于治疗。
Med J Aust. 1996 Jan 15;164(2):121-4. doi: 10.5694/j.1326-5377.1996.tb101371.x.
7
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.耐多药结核病的标准短程化疗：6个国家的治疗结果
JAMA. 2000 May 17;283(19):2537-45. doi: 10.1001/jama.283.19.2537.
8
Drug resistant tuberculosis: back to sanatoria, surgery and cod-liver oil?耐药结核病：要回归疗养院、手术和鱼肝油疗法吗？
Eur Respir J. 1995 Jul;8(7):1073-5. doi: 10.1183/09031936.95.08071073.
9
Challenges and Outlooks in Multi-drug Resistant Tuberculosis.耐多药结核病的挑战与展望
Arch Bronconeumol. 2017 Aug;53(8):417-418. doi: 10.1016/j.arbres.2017.01.018. Epub 2017 Mar 14.
10
Multiple drug resistant tuberculosis.多重耐药结核病
J Clin Pathol. 1997 Feb;50(2):89-90. doi: 10.1136/jcp.50.2.89.
本文引用的文献
1
Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.异烟肼预防治疗耐多药结核病接触者。
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1159-1168. doi: 10.1164/rccm.201908-1576OC.
2
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial.左氧氟沙星对比安慰剂治疗耐多药结核病患者接触者中潜伏性结核病（VQUIN MDR 试验）：一项随机对照试验方案。
BMJ Open. 2020 Jan 2;10(1):e033945. doi: 10.1136/bmjopen-2019-033945.
3
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.全球潜伏性耐多药结核病负担：基于数学模型的趋势和估计。
Lancet Infect Dis. 2019 Aug;19(8):903-912. doi: 10.1016/S1473-3099(19)30307-X. Epub 2019 Jul 4.
4
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.利福喷汀加异烟肼预防 HIV 相关结核病：一个月疗程。
N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808.
5
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).左氧氟沙星与安慰剂预防耐多药结核病儿童接触者结核病：一项III期整群随机对照试验（TB-CHAMP）的研究方案
Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0.
6
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核：利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
7
Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation.在家托幼中心接触耐多药结核病的儿童：一项接触者调查
Int J Tuberc Lung Dis. 2014 Nov;18(11):1292-8. doi: 10.5588/ijtld.13.0872.
8
Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010.1995-2010 年澳大利亚维多利亚州接触耐多药结核病接触者的长期随访。
Int J Tuberc Lung Dis. 2012 Oct;16(10):1320-5. doi: 10.5588/ijtld.12.0092. Epub 2012 Aug 3.
9
Three months of rifapentine and isoniazid for latent tuberculosis infection.利福喷丁和异烟肼治疗潜伏性结核感染 3 个月。
N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.
10
Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort.耐多药结核病患者密切接触者的结核病风险：一项全国性队列研究
Thorax. 2009 Mar;64(3):271. doi: 10.1136/thx.2008.100974.
Zotero 插件